Name: MBX Biosciences, Inc. (MBX) Balance Sheet
Creator: FinSpry

MBX Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for MBX Biosciences, Inc. (MBX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	49.35	30.52	24.21
Short-Term Investments	212.80	50.15	18.25
Cash & Short-Term Investments	262.15	80.68	42.46
Accounts Receivable	0.68	0.21	0.14
Inventory	0.00	0.00	0.00
Other Current Assets	0.80	2.45	0.08
Total Current Assets	267.29	83.47	44.21
Non-Current Assets
Property, Plant & Equipment (Net)	1.20	0.67	0.84
Other Non-Current Assets	0.05	0.05	0.04
Total Non-Current Assets	1.25	0.72	0.88
Total Assets	268.54	84.18	45.10
Current Liabilities
Accounts Payable	5.34	1.39	0.98
Short-Term Debt	0.17	0.00	0.00
Accrued Liabilities	3.22	2.38	1.19
Other Current Liabilities	5.55	0.00	0.00
Total Current Liabilities	11.05	3.93	3.43
Non-Current Liabilities
Long-Term Debt	0.00	0.17	0.32
Other Non-Current Liabilities	0.04	0.19	0.07
Total Non-Current Liabilities	0.04	152.72	84.27
Total Liabilities	11.09	4.29	87.70
Stockholders' Equity
Common Stock	0.01	0.00	0.00
Retained Earnings	-137.51	-75.58	-43.02
Accumulated Other Comprehensive Income	0.06	0.06	0.00
Additional Paid-in Capital	394.89	3.05	0.41
Shares Outstanding	33.42	31.85	31.85
Total Stockholders' Equity	257.44	79.89	-42.61
Total Liabilities & Equity	268.54	84.18	45.10